Stay updated on Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.6.3 replaces v3.6.2 in the history. This reflects a platform update to the page.
    Difference
    0.1%
    Check dated 2026-07-06T16:29:17.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.2 was added to the study's record history, and the previous revision v3.6.0 was removed. This reflects an update to the documented revision history for the record.
    Difference
    0.1%
    Check dated 2026-06-29T10:48:15.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Recruitment is now closed in the study history, indicating no further participants are being sought. A new revision entry (v3.6.0) was added and the prior revision (v3.5.5) was removed, updating the record version.
    Difference
    0.5%
    Check dated 2026-06-15T05:32:24.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.5.5 has been added to the study record history. The previous revision v3.5.4 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-06-08T04:20:46.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page history now shows a new revision label v3.5.4, replacing the previous v3.5.3. This reflects a new build of the page history rather than changes to the study data or text.
    Difference
    0.1%
    Check dated 2026-05-17T09:59:27.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page’s interface/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than any change to the underlying study or its details.
    Difference
    0.1%
    Check dated 2026-04-24T22:40:14.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.